Drugs / Sereflo
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01274325 | Feb 2011 → Apr 2013 | asthma | Mahidol University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sereflo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01274325 ↗ |
| Route | Inhaled | “Patients take sereflo (25/125) 2 puffs twice a day for 4 weeks” NCT01274325 ↗ |